Here are five other recent ratings for Smith & Nephew:
• JPMorgan & Chase Co.: Neutral rating
• BNP Paribas: Outperform rating
• AlphaValue: Buy rating
• Sanford C. Bernstein: Outperform rating
• Consensus rating is “Hold”
The average price target of GBX 1,135.63 is $16.99.
More articles on orthopedic devices:
Spine device stock report: 5 key companies—April 23
Medacta makes huge donation to OREF
8 huge trends in venture capital money for healthcare start-ups
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.